| Dolin, R; Graham, B S; Greenberg, S B et al. (1991) The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network. Ann Intern Med 114:119-27 |
| Tyler, D S; Stanley, S D; Zolla-Pazner, S et al. (1990) Identification of sites within gp41 that serve as targets for antibody-dependent cellular cytotoxicity by using human monoclonal antibodies. J Immunol 145:3276-82 |
| Tyler, D S; Stanley, S D; Nastala, C A et al. (1990) Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects. J Immunol 144:3375-84 |
| Tyler, D S; Lyerly, H K; Weinhold, K J (1989) Anti-HIV-1 ADCC. AIDS Res Hum Retroviruses 5:557-63 |
| Tyler, D S; Nastala, C L; Stanley, S D et al. (1989) GP120 specific cellular cytotoxicity in HIV-1 seropositive individuals. Evidence for circulating CD16+ effector cells armed in vivo with cytophilic antibody. J Immunol 142:1177-82 |
